University of Ioannina
Μελέτη της ανοσοϊστοχημικής έκφρασης ανδρογονικού υποδοχέα, ρυθμιστών σηματοδότησης και δεικτών ενεργότητας της AR οδού και ύπαρξης μεταλλάξεων στον καρκίνο του μαστού
Abstract
dc:descriptionThe study population consists of histological blocks of paraffin adenocarcinoma of breast tissuemicroarrays (TMA) (N = 700). Tissues are derived from patients with T1-4 N0-2 M0 ER any IHC PgRany HER2 any tumor treated according to standard therapeutic protocols of HeCOG comprisingadjuvant therapy with taxane and / or anthracycline based regimens. Complete clinical and pathological data are available in patient’s charts. Of the 700 samples, 646 were evaluable for staining and reading even one of the studied FKBP5, TMPRSS2 and PSA proteins. Frequency histograms, the score and percentage of cells expressing nuclear FKBP5, cytoplasmic PSA, cytoplasmic and membraneTMPRSS2 were documented and analyzed for normal cut off valueidentification. Positivity of staining was considered at even 1%. The expression of the respectiveprotein was considered high when it was higher and lower when it was lower or equal to the optimum cut off value respectively and was studied as a variable agent in the assay. Analysis of the percentage of cells with positive expression of the above proteins revealed the cut off. For TMPRSS2 the cut off was at 80 for the cytoplasmic PSA of 15 while for the nuclear expression of FKBP5 two cut offs, 65 and 85 were identified, both of which were examined and analyzed for their prognostic and predictive value in the analysis. Similarly, the cut-off of the H-score for TMPRSS2 was set at 100, for PSA 50 and FKBP5 150. In a subset of 78 samples from University Hospital of Ioanninapatients, mutations of the AR gene was sought without any positive outcome. Regarding the clinical outcome, the findings of the study are the following, The expression of the TMPRSS2 protein with the cut off at 80 in the univariate analysis is associated with a tendency to benefit in the survival-free interval (p = 0.072, HR: 0.41, 95% CI: 0.15-1.08) and benefit in overall survival (p = 0.037, HR: 0.3, 95% CI: 0.1 -0.93) in HER2 enriched volumes. In multivariate analysis, we see that the benefit for OS (p = 0.037, HR: 0.3, 95% CI: 0.1-0.93) is confirmed in these tumors. For the FKBP5 protein the results are clearer. Briefly, in the univariate analysis, expression of FKBP5 protein was found to have a trend to statistically significant correlation with DFS with cut off 65 (HR: 0.74, 95% CI 0.54-1.03, p = 0.072), statistically significant correlation with H score 150 (HR : 0.66, 95% CI 0.5 -0.87, p = 0.03) while with respect to OS a statistically significant correlation with H score 150(HR: 0.61, 95% CI 0.42 - 0.78, p <0.001) 8was shown. In the multivariate analysis there was astatistically significant correlation of FKBP5 expression with H score 150 for both DFS (HR: 0.61, 95% CI 0.44-0.83, p = 0.002) and OS (HR: 0.53, 95% CI 0.37 - 0.75, p & lt; 0.001). With regard to the molecular subtypes for Luminal A tumors, there is a trend in favor of DFS with FKBP5 expression with cut off 85 (HR: 0.62, 95% CI 0.36-1.08, p = 0.092) and H score 150 (HR: 0.59,95% CI 0.34-1.04, p = 0.067). Multivariate analysis confirmed the benefit in DFS with H score 150 (HR:0.56, 95% CI 0.32 -0.99, p = 0.045). For Luminal B, FKBP5 expression with H score 150, both in univariate and multivariate, there is a benefit in overall survival (HR: 0.44, 95% CI 0.24 -0.80, p = 0.007, respectively). In luminal HER2 tumors, expression of FKBP5 with H score of 150 showed a benefit to OS in both univariate (HR: 0.31, 95% CI 0.12-0.81, p = 0.017) and multivariate analysis (HR: 0.32, 95 CI 0.13-0.84, p = 0.02). In addition, univariate analysis showed a trend for DFS (HR: 0.49, 95% CI 0.22-1.13, p= 0.093). For TNBC tumors in univariate analysis the expression of FKBP5 protein had statistically significant correlation with DFS with both cut off 85 (HR: 0.44, 95% CI 0.21-0.9, p = 0.025) and H score 150 HR:0.41, 95% CI 0.18-0.93, p = 0.032). In multivariate analysis cut-off expression 85 maintained the benefit in DFS (HR: 0.44, 95% CI 0.22 -0.92, p = 0.028) with H score 150 tended to benefit in DFS (HR: 0.45, 95% CI 0.2 -1.01, p = 0.052).Finally, for PSA, the statistical analysis resulted in DFS multivariate analysis with cut off at 50 (HR:3.27, 95% CI 1.17-9.16, p = 0.024), although it was found to be expressed only in 59 of all samples. From the above findings, it appears that the expression of FKBP5, TMPRSS2 and PSA is associated with a better clinical outcome, thus obtaining a predictive and predictive character. In addition, through their association with other molecular pathways, such as mTOR, they appear to play a larger role than we thought in carcinogenesis and tumor suppression. It remains to be confirmed by other studies that the role of these biomarkers is predictive, predictive and why not molecular targets.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Fotopoulos, Georgios
- Φωτόπουλος, Γεώργιος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46986